Insider Sell: Vaxcyte Inc CFO Andrew Guggenhime Disposes of 8,000 Shares
Andrew Guggenhime, the President and CFO of Vaxcyte Inc (NASDAQ:PCVX), has sold 8,000 shares of the company on February 20, 2024, according to a recent SEC Filing. Vaxcyte Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative vaccine candidates. The company aims to improve global health through the power of its vaccine technologies.
The insider's transaction history indicates that over the past year, Andrew Guggenhime has sold a total of 54,000 shares and has not made any purchases of the company's stock.
The insider transaction history for Vaxcyte Inc reveals a pattern of insider selling, with 26 insider sells recorded over the past year and no insider buys during the same period.
On the date of the insider's most recent transaction, shares of Vaxcyte Inc were trading at $74.53, giving the company a market capitalization of approximately $7.967 billion.
The data provided reflects the transactions and valuation of Vaxcyte Inc as of the specified dates and does not include any analysis or adjectives that may convey subjective opinions.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
